Search - tctmd.com

Displaying 261 - 280 of 347

Sort: Relevancy | Date

Presentation TVT 2022

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Presenter: David Cohen

June 08, 2022

Presentation TVT 2022

Bicuspid TAVR Clinical Evidence: Data Takeaways and Evidence Gaps

Presenter: Steven Yakubov

June 08, 2022

Presentation TVT 2022

Technical Pearls: Valve Choice, Sizing, and Positioning

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

Explant Versus Redo TAVR After TAVR Failure: Outcomes From the EXPLANTORREDO-TAVR International Registry

Presenter: Syed Zaid

June 08, 2022

Presentation TVT 2022

When Is Surgery the First Choice?

Presenter: Mathew Williams

June 08, 2022

Presentation TVT 2022

Forget Sievers, CT Phenotyping and Calcium Reign Supreme in Bicuspid Disease!

Presenter: Hasan Jilaihawi

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Presenter: Haim Danenberg

June 08, 2022

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

Presentation TVT 2022

Health-Related Quality of Life after TAVR According to Baseline Flow State and Aortic Valve Gradients

Presenter: Ibrahim Khaleel

June 08, 2022

Presentation TVT 2022

Alternative Transcatheter Solutions

Presenter: Lauren Ranard

June 08, 2022

Presentation TVT 2022

Late Valvuloplasty for Transcatheter Heart Valve Dysfunction

Presenter: Mariama Akodad

June 08, 2022

Presentation TVT 2022

Frequency, Mechanisms, and Current Management

Presenter: Nir Uriel

June 08, 2022

Presentation TVT 2022

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Presenter: Matti Adam

June 08, 2022

Presentation TVT 2022

Unexpected complication after TAVR

Presenter: Itsik Ben-Dor

June 08, 2022

Advertisement

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Bicuspid TAVR Clinical Evidence: Data Takeaways and Evidence Gaps

Technical Pearls: Valve Choice, Sizing, and Positioning

Explant Versus Redo TAVR After TAVR Failure: Outcomes From the EXPLANTORREDO-TAVR International Registry

When Is Surgery the First Choice?

Forget Sievers, CT Phenotyping and Calcium Reign Supreme in Bicuspid Disease!

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Health-Related Quality of Life after TAVR According to Baseline Flow State and Aortic Valve Gradients

Alternative Transcatheter Solutions

Late Valvuloplasty for Transcatheter Heart Valve Dysfunction

Frequency, Mechanisms, and Current Management

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Unexpected complication after TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content